Adult nicotine consumers deserve options—products that satisfy, evolve with expectations, and can potentially reduce risk. They also deserve accurate information to make informed choices. We’re committed to delivering innovative smoke-free products and brands across e-vapor,

We’re building a pipeline of smoke-free products by combining expertise in science, engineering, and behavioral research—helping adult smokers 21+ move toward a smoke-free future. Learn more: https://t.co/DaRwa2JJOE #SmokeFreeFuture #Innovation #HarmReduction

At Altria, we invest in research and technology to develop smoke-free products and generate the scientific evidence needed for FDA applications. Our regulatory science team generates the scientific evidence needed to demonstrate that smoke-free and nicotine tobacco products

We’re pleased that the FDA authorized marketing of certain on! PLUS nicotine pouches, marking a significant milestone in our journey of Moving Beyond Smoking®. We believe that on! PLUS products provide a compelling smoke-free alternative and today’s product authorizations

We are Moving Beyond Smoking®. Through science and innovation, Altria is driving transformation to create a better future. From advanced research to breakthrough technologies, we’re committed to meaningful progress for adult consumers and public health. #SmokeFreeFuture

On National STEM Day, we celebrate the scientists, engineers, technologists, and analysts who bring curiosity, creativity, and precision to everything we do. Their work helps us solve complex challenges and shape the future of our industry. We’re proud to support STEM excellence

Millions of adults who continue to smoke combustible cigarettes in the U.S. do not switch to reduced-risk alternatives because of misperceptions about nicotine and the relative risks of tobacco products. Correcting these misperceptions is critical in order for these individuals

At GTNF 2025, Mohamadi led a conversation on one of the most significant barriers to harm reduction: nicotine misperceptions. Accurate information empowers adults who smoke, and the health professionals who support them, to make informed choices about switching to smoke-free

Mohamadi Sarkar presented at the FDLI Tobacco and Nicotine Products Regulation and Policy Conference today on Reducing Harm: Clinical Conversations, Public Perception & the FDA’s Role. This session provided critical insights into advancing harm reduction through science-based

At GTNF 2025, Paige led a timely panel discussion on the evolving U.S. regulatory landscape, emphasizing the need for clear, consistent frameworks that enable responsible product innovation and harm reduction. #PolicyLeadership #RegulatoryExcellence #GTNF2025

Merci, Annecy! What an inspiring week at the 2025 CORESTA Product Science & Product Technology Conference, set against the backdrop of the French Alps. Throughout the event, thought-provoking discussions highlighted the critical role of rigorous research, collaboration, and

From public health to regulatory science, Raheema S. Muhammad-Kah, MSPH, PhD., brings more than a decade of experience in biostatistics and population health to advance our Vision of Moving Beyond Smoking®. As Principal Scientist II, Population Sciences at Altria Client

With a deep background in behavioral research and tobacco regulatory science, Josh Karelitz, PhD., applies his expertise to advance our Vision of Moving Beyond Smoking®. As Principal Regulatory Scientist II in Regulatory Affairs at Altria Client Services, Josh leads abuse

Science drives Altria’s commitment to tobacco harm reduction. Through strategic investments in research and technology, we are advancing the development of smoke-free products and supporting the science needed for FDA product applications. Learn more about our innovative

We’re looking forward to joining global experts at the 2025 CORESTA Product Science and Product Technology Conference in Annecy, France, where scientists, researchers, and industry leaders will come together to advance scientific discussion across the tobacco industry. Our 13

A critical barrier to advancing harm reduction and helping millions of adults switch to smoke-free products is pervasive misperceptions about nicotine and the relative risks of tobacco products. Dr. Mohamadi Sarkar, Fellow, Scientific Strategy and Analysis, Regulatory Affairs,

Next week, thought leaders from science, public health, regulation, industry, and advocacy will convene in Brussels, Belgium for the Global Tobacco and Nicotine Forum. This year’s theme, 'Real World Evidence: The Race to Reduce Harm,' focuses on the opportunities and challenges

We’re proud to join global thought leaders at the 2025 Global Tobacco & Nicotine Forum in Brussels, Belgium. As we continue advancing our vision for a smoke-free future, we look forward to meaningful dialogue on innovation, harm reduction, and responsible leadership. #GTNF2025

At Altria, we’re focused on reducing the harm of tobacco products and advancing a smoke-free future. Through innovation and science, we’re providing adult smokers with better alternatives. Learn more about our commitment to harm reduction: https://t.co/aa5vlrb8VD

We’re Moving Beyond Smoking®. Altria is committed to reducing the harm of tobacco products by advancing innovative alternatives for adult smokers 21+. Learn more about our vision for a smoke-free future: https://t.co/aa5vlrb8VD #TobaccoHarmReduction #Innovation #Altria